Literature DB >> 16755363

Pharmacokinetic parameters of (R)-(-) and (S)-(+)-flurbiprofen in dairy bovines.

L Igarza1, A Soraci, N Auza, H Zeballos.   

Abstract

The aim of the study was to evaluate the pharmacokinetics of flurbiprofen (FBP) in different age groups and physiological status groups in dairy cattle. Ten Argentine Holstein bovines were divided into three different groups: 3 cows in early lactation, 3 cows in gestation and 4 newborn calves. Based on previous experience, all the animals received racemic FBP (50:50) at a dose of 0.5 mg/kg by intravenous administration. Blood samples were taken at predetermined times after administration of flurbiprofen. Plasma enantiomer concentrations were measured by HPLC. Total body clearance (ClB) of (S)-(+)-FBP was higher in calves than in cows (114.5, 136.4, 121.4, 128.9 microg/ml vs 22.0, 24.2, 46.5 microg/ml and 27.6, 25.3, 34.6 microg/ml). In calves the disposition kinetics showed stereoselective behaviour. Area under the concentration-time curve (AUC) was higher and Cl(B) and steady-state volume of distribution (V(ss)) were lower for (R)-(-)-FBP than for (S)-(+)-FBP. In cows, stereoselectivity was observed in Cl(B) and elimination half-life (t(1)/2) only in the early lactation group. In this study, enantioselective metabolic behaviour of FBP under the physiological situations studied was found. Hence, it is possible that both enantiomers of flurbiprofen may contribute to the drug's therapeutic effects, but further studies with the administration of separate enantiomers will be required to elucidate their metabolism.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16755363     DOI: 10.1007/s11259-006-3241-4

Source DB:  PubMed          Journal:  Vet Res Commun        ISSN: 0165-7380            Impact factor:   2.459


  31 in total

1.  High-performance liquid chromatographic assay of ketoprofen enantiomers in human plasma and urine.

Authors:  R T Foster; F Jamali
Journal:  J Chromatogr       Date:  1987-05-15

Review 2.  Importance of drug enantiomers in clinical pharmacology.

Authors:  K Williams; E Lee
Journal:  Drugs       Date:  1985-10       Impact factor: 9.546

3.  Physiology and treatment of pain and inflammation. Analgesic effects of flurbiprofen.

Authors:  T G Kantor
Journal:  Am J Med       Date:  1986-03-24       Impact factor: 4.965

4.  The effect of hormones on the expression of five isoforms of UDP-glucuronosyltransferase in primary cultures of rat hepatocytes.

Authors:  Y Q Li; D A Prentice; M L Howard; M L Mashford; P V Desmond
Journal:  Pharm Res       Date:  1999-02       Impact factor: 4.200

Review 5.  The metabolic chiral inversion and dispositional enantioselectivity of the 2-arylpropionic acids and their biological consequences.

Authors:  J Caldwell; A J Hutt; S Fournel-Gigleux
Journal:  Biochem Pharmacol       Date:  1988-01-01       Impact factor: 5.858

6.  Enantioselective disposition of 2-arylpropionic acid nonsteroidal anti-inflammatory drugs. IV. Ketoprofen disposition.

Authors:  A Abas; P J Meffin
Journal:  J Pharmacol Exp Ther       Date:  1987-02       Impact factor: 4.030

7.  Variability of inversion of (R)-flurbiprofen in different species.

Authors:  S Menzel-Soglowek; G Geisslinger; W S Beck; K Brune
Journal:  J Pharm Sci       Date:  1992-09       Impact factor: 3.534

8.  The development of hepatic drug-metabolizing enzyme activity in the neonatal calf and its effect on drug disposition.

Authors:  S E Shoaf; W S Schwark; C L Guard; J G Babish
Journal:  Drug Metab Dispos       Date:  1987 Sep-Oct       Impact factor: 3.922

Review 9.  Clinical pharmacokinetics of flurbiprofen and its enantiomers.

Authors:  N M Davies
Journal:  Clin Pharmacokinet       Date:  1995-02       Impact factor: 6.447

10.  Characterization of the in vitro glucuronidation of flurbiprofen enantiomers.

Authors:  M Hamdoune; J Mounie; J Magdalou; T Masmoudi; H Goudonnet; A Escousse
Journal:  Drug Metab Dispos       Date:  1995-03       Impact factor: 3.922

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.